ArticleCaspian journal of internal medicine2025

De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: An initial Iranian experience.

Sepideh Paybast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.